Navigation Links
ZIOPHARM Presents Data on Orally Active ZIO-201 at AACR

, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identifies proprietary and related molecules for better patient treatment. For more information, visit www.ziopharm.com.

Forward-Looking Safe Harbor Statement:

This press release contains forward-looking statements for ZIOPHARM Oncology, Inc. that involve risks and uncertainties that could cause the Company's actual results to differ materially from the anticipated results and expectations expressed in these forward-looking statements. These statements are based on current expectations, forecasts and assumptions that are subject to risks and uncertainties, which could cause actual outcomes and results to differ materially from these statements. Among other things, there can be no assurance that any of the Company's development efforts relating to its product candidates will be successful, or such product candidates will be successfully commercialized. Other risks that affect forward-looking information contained in this press release include the possibility of being unable to obtain regulatory approval of the Company's product candidates, the risk that the results of clinical trials may not support the Company's claims, and risks related to the Company's ability to protect its intellectual property and its reliance on third parties to develop its product candidates. The Company assumes no obligation to update these forward-looking statements, except as required by law.

ZIOP-G

Contact

ZIOPHARM Oncology, Inc.
Investors
Suzanne McKenna, 646-214-0703
smckenna@ziopharm.com
or
Media
Tina Posterli, 917-322-2565
tposterli@r
'"/>




Page: 1 2 3

Related medicine technology :

1. ZIOPHARM to Present at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR
3. ZIOPHARM Presents Unique Mechanism Data for Indibulin at AACR
4. ZIOPHARM Presents ZIO-201 Lymphoma Data at ISH
5. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
6. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
7. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
8. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
9. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
10. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
11. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ZIOPHARM Presents Data Orally Active ZIO AACR
(Date:5/22/2013)... May 22, 2013 Advanced Prenatal Therapeutics (APT), ... that will help alleviate the high blood pressure and ... is expected to be the first medical device specifically ... and fetal death. Every year, preeclampsia affects ... States . It is characterized by high blood ...
(Date:5/22/2013)... May 22, 2013 Attorney Advertising -- Bronstein, ... on behalf of purchasers of the securities of ... AMAG -News).  The investigation focuses on whether the ... On May 22, 2013, Shares of ... after the company announced in regulatory filing that ...
(Date:5/22/2013)... , May 22, 2013  The Leukemia & Lymphoma ... to Valor Biotherapeutics, LLC, a joint venture between ImmunGene ... manufacturing, and a Phase I clinical trial for a ... faced by many patients with indolent lymphomas who do ... Valor,s protein, IGN002, is a new class of ...
Breaking Medicine Technology:Advanced Prenatal Therapeutics - Using Targeted Apheresis to Treat Preeclampsia 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4
... PARSIPPANY, N.J., Jan. 31, 2011 PDI, Inc. (Nasdaq: ... officer, is scheduled to present at the UBS 21st Annual Global ... at the Grand Hyatt New York. The live ... company,s website at http://www.pdi-inc.com . The webcast will be archived ...
... Calif., Jan. 31, 2011 OXIS International, Inc., (OTC ... today announced highly favorable final results from an initial ... patent-pending ERGOFLEX™ joint health formula, launched commercially ... of pain was statistically significant after as little as ...
Cached Medicine Technology:Final Results from ERGOFLEX Study Show Statistically Significant Reduction in Joint Pain in as Little as One Week 2Final Results from ERGOFLEX Study Show Statistically Significant Reduction in Joint Pain in as Little as One Week 3Final Results from ERGOFLEX Study Show Statistically Significant Reduction in Joint Pain in as Little as One Week 4
(Date:5/22/2013)... CA (PRWEB) May 22, 2013 Dr. Andrew ... to painful scalpel surgery with the Laser Assisted New Attachment ... is raising awareness about the connections between gum disease and ... concerns in the United States today, and is linked to ... of bacteria found in the infected gum pockets. , ...
(Date:5/22/2013)... Hosted by the California Dental Association Foundation ... more than $1.6 million in charitable dental services during ... , The California Dental Association Foundation and the ... dental services and oral health education to Californians who ... held by CDA and CDAF in the past 12 ...
(Date:5/22/2013)... A new study shows there is a gender ... American young children one that does not appear ... United States, girls had higher levels of self-regulation than ... their behavior and impulses, follow directions, and persist on ... and college completion, in past studies by Oregon State ...
(Date:5/22/2013)... ID (PRWEB) May 22, 2013 Bodybuilding.com ... This Memorial Day (May 27, 2013) Bodybuilding.com will be donating ... of the amount. , “We are extremely grateful for ... the Armed Forces,” said Ryan DeLuca, CEO and founder of ... heroes who have sacrificed so much. Hire Heroes USA is ...
(Date:5/22/2013)... of Michigan study challenges previous research that suggests ... The study, a collaboration between researchers at U-M ... deeper into the controversial argument over whether MLB ... pitchers of the same race. It found little ... Winfree, associate professor of sport management at the ...
Breaking Medicine News(10 mins):Health News:For Stroke Awareness Month, Dr. Andrew Satlin is Raising Awareness of the Connections Between Gum Disease and Stroke and Offers Encino, CA Laser Gum Surgery for Treatment 2Health News:Two-day San Jose Dental Clinic Provides More Than $1.6 Million in Care 2Health News:'Boys will be boys' in US, but not in Asia 2Health News:'Boys will be boys' in US, but not in Asia 3Health News:In the Spirit of Memorial Day, Bodybuilding.com is Donating a Portion of Their Sales to Hire Heroes 2Health News:U-M study challenges notion that umpires call more strikes for pitchers of same race 2
... ... ... Advocate Christ Medical Center and Hope Children’s Hospital was awarded the Morehead Apex Workplace ... the Ritz-Carlton in Charlotte, N.C. , , ,Christ Medical Center and Hope Children’s Hospital ...
... lead to new birth control for men , WEDNESDAY, April ... proteins called PLA2s play a vital role in sperm function ... The findings could improve understanding of male infertility and lead ... infertility. , In one study, Japanese researchers found that the ...
... ... except if the girls in the salon chair are battling cancer or other serious illness. Then, ... ... at the Tipperary Hair Salon in Beverly Hills, California, approximately 35 such girls and their sisters ...
... ... District to Develop a 100 Percent Lead Free Bubbler Retrofit Kit , ... Los Angeles, CA (Vocus) April 28, 2010 -- ... and chillers and a division of Acorn Engineering Company, announces a 100 percent lead-free bubbler ...
... 28, 2010 Many of the world,s leading experts in ... first-of-its-kind conference in Kansas City to change the way childhood ... hosted by Children,s Mercy Hospitals and Clinics, is to apply ... unique make-up of pediatric patients and improve outcomes. ...
... ... about supporting you after the sale when you believe you need to return an item. ... with complete confidence knowing that their purchase can be returned for a replacement or a ... ...
Cached Medicine News:Health News:Advocate Christ Medical Center Presented The 2009 Morehead Apex Workplace of Excellence Award 2Health News:Advocate Christ Medical Center Presented The 2009 Morehead Apex Workplace of Excellence Award 3Health News:Pediatric Patients and Siblings Enjoy Beverly Hills Beauty Makeover 2Health News:Pediatric Patients and Siblings Enjoy Beverly Hills Beauty Makeover 3Health News:The Acorn Aqua's Lead Free Bubbler 2Health News:Advances in personalized medicine take center stage 2Health News:National Allergy Supply, The Allergy Products Company Recommended By More Than 9,500 Doctors Nationwide, Announces 100% Unconditional Satisfaction Guarantee 2
... The Hudson RCI ... a patented "split prong" ... oxygen supply tubes with ... provides the utmost control ...
... equivalent of 7.5 liters out of your five-liter ... two machines for your high-flow patients! , ... Devices function like standard conservers, because they extend ... required to saturate a patient. However, they ...
Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....
Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....
Medicine Products: